<aside> 💡 CD5+, CD20+, CD43+, cyclin D1+, FMC7+, CD23**-/+, CD10-**/+ t(11;14)(q13,q23) → CCND1- IGH translocation (90~99%) SOX11+ (>90%); SOX11- → better prognosis

</aside>

Epidemiology

Clinical Manifestations

Immunophenotype

Morphology

<aside> 💡 Histologic transformation to large B-cell lymphoma does not occur.

</aside>

Subtypes